#ClinGen Region Curation Results
#24 Nov,2021
#Genomic Locations are reported on GRCh38 (hg38): GCF_000001405.36
#https://www.ncbi.nlm.nih.gov/projects/dbvar/clingen
#to create link: https://www.ncbi.nlm.nih.gov/projects/dbvar/clingen/clingen_region.cgi?id=key
#ISCA ID	ISCA Region Name	cytoBand	Genomic Location	Haploinsufficiency Score	Haploinsufficiency Description	Haploinsufficiency PMID1	Haploinsufficiency PMID2	Haploinsufficiency PMID3	Haploinsufficiency PMID4	Haploinsufficiency PMID5	Haploinsufficiency PMID6	Triplosensitivity Score	Triplosensitivity Description	Triplosensitivity PMID1	Triplosensitivity PMID2	Triplosensitivity PMID3	Triplosensitivity PMID4	Triplosensitivity PMID5	Triplosensitivity PMID6	Date Last Evaluated	Loss phenotype OMIM ID	Triplosensitive phenotype OMIM ID
ISCA-46739	Yq11.223 population region (DGV_Gold_Standard_June_2021_gssvL138428)	Yq11.223	chrY:23707042-24000812	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46738	Yq11.223 population region (DGV_Gold_Standard_June_2021_gssvL138419)	Yq11.223	chrY:22215719-22319024	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46737	Xq27.3 population region (DGV_Gold_Standard_June_2021_gssvL137799)	Xq27.3	chrX:143513946-143712498	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46736	Xq21.1 population region (DGV_Gold_Standard_June_2021_gssvL136501)	Xq21.1	chrX:76917203-76920597	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46735	Xp11.23 population region (DGV_Gold_Standard_June_2021_gssvL136075)	Xp11.23	chrX:48020900-48092718	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46734	Xq28 population region (DGV_Gold_Standard_June_2021_gssvG41365)	Xq28	chrX:154144372-154195156	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46733	Xq24 population region (DGV_Gold_Standard_June_2021_gssvG41158)	Xq24	chrX:120872658-120990043	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46732	22q11.23 population region (DGV_Gold_Standard_June_2021_gssvG24415)	22q11.23	chr22:25307292-25389268	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46731	22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL77050)	22q11.21	chr22:21512587-21554998	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46730	22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL77049)	22q11.21	chr22:21357191-21387766	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46729	22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL77047)	22q11.21	chr22:21458269-21562279	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46728	22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL76981)	22q11.21	chr22:18578203-18649330	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46727	22q11.22 population region (DGV_Gold_Standard_June_2021_gssvL77120)	22q11.22	chr22:22881268-22896812	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46726	22q11.23 population region (DGV_Gold_Standard_June_2021_gssvL77244)	22q11.23	chr22:23972100-23992644	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46725	22q11.23 population region (DGV_Gold_Standard_June_2021_gssvL77238)	22q11.23	tbd	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46724	12p11.2 population region (DGV_Gold_Standard_June_2021_gssvG23340)	21p11.2	chr21:10807602-11085101	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46723	21q11.2 population region (DGV_Gold_Standard_June_2021_gssvL74506)	21q11.2	chr21:13585184-13829682	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46722	21q22.3 population region (DGV_Gold_Standard_June_2021_gssvL75982)	21q22.3	chr21:43549137-43554132	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46721	21q22.3 population region (DGV_Gold_Standard_June_2021_gssvL76000)	21q22.3	chr21:43550452-43551866	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46720	20p11.22 population region (DGV_Gold_Standard_June_2021_gssvL71898)	20p11.22	chr20:21505887-21516082	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46719	20q11.21 population region (DGV_Gold_Standard_June_2021_gssvL72187)	20q11.21	chr20:30274364-30301403	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46718	19p12 population region (DGV_Gold_Standard_June_2021_gssvL57428)	19p12	chr19:21904297-22959138	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46717	19q13.42 population region (DGV_Gold_Standard_June_2021_gssvG19479)	19q13.42	chr19:55769264-55778196	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46716	19p12 population region (DGV_Gold_Standard_June_2021_gssvL57316)	19p12	chr19:20412004-20542598	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46715	19p13.12 population region (DGV_Gold_Standard_June_2021_gssvL57062)	19p13.12	chr19:15616920-15676907	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46714	19q13.32 population region (DGV_Gold_Standard_June_2021_gssvL58890)	19q13.32	chr19:46119085-46125218	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46713	19q13.42 population region (DGV_Gold_Standard_June_2021_gssvL59370)	19q13.42	chr19:53436136-53473398	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46712	18q21.1 population region (DGV_Gold_Standard_June_2021_gssvG17872)	18q21.1	chr18:46962327-46978121	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46711	18p11.21 population region (DGV_Gold_Standard_June_2021_gssvG17388)	18p11.21	chr18:14432554-14565139	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46710	18q11.2 population region (DGV_Gold_Standard_June_2021_gssvL52661)	18q11.2	chr18:26167795-26171731	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46709	18p11.22 population region (DGV_Gold_Standard_June_2021_gssvL52196)	18p11.22	chr18:9784175-9793227	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46708	18p11.31 population region (DGV_Gold_Standard_June_2021_gssvL51911)	18p11.31	chr18:3568885-3571732	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46707	17q21.2 population region (DGV_Gold_Standard_June_2021_gssvG16538)	17q21.2	chr17:41375466-41383480	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46706	17q12 population region (DGV_Gold_Standard_June_2021_gssvG16427)	17q12	chr17:36175580-36196832	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46705	17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16095)	17p11.2	chr17:18456500-18473362	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46704	17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16067)	17p11.2	chr17:18458425-18520558	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46703	17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16017)	17p11.2	chr17:16808258-16821368	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46702	17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16012)	17p11.2	chr17:16757446-16804519	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46701	17p11.2 population region (DGV_Gold_Standard_June_2021_gssvL48488)	17p11.2	chr17:18456476-18473409	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46700	17p11.2 population region (DGV_Gold_Standard_June_2021_gssvL48476)	17p11.2	chr17:18515275-18561800	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46699	17p11.2 population region (DGV_Gold_Standard_June_2021_gssvL48375)	17p11.2	chr17:16808292-16821367	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46698	17q12 population region (DGV_Gold_Standard_June_2021_gssvL49126)	17q12	chr17:36182399-36224174	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46697	17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49379)	17q21.2	chr17:41227065-41240192	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46696	17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49386)	17q21.2	chr17:41272898-41277342	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46695	17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49384)	17q21.2	chr17:41266736-41274275	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46694	17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49383)	17q21.2	chr17:41228039-41236306	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46693	16q23.1 population region (DGV_Gold_Standard_June_2021_gssvG15270)	16q23.1	chr16:74354039-74425264	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46692	16q22.2 population region (DGV_Gold_Standard_June_2021_gssvG15245)	16q22.2	chr16:72054616-72082165	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46691	16p12.2 population region (DGV_Gold_Standard_June_2021_gssvG14372)	16p12.2	chr16:21500755-21584256	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46690	16p13.3 population region (DGV_Gold_Standard_June_2021_gssvL41949)	16p13.3	chr16:1239936-1245279	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46689	16p12.1 population region (DGV_Gold_Standard_June_2021_gssvL43366)	16p12.1	chr16:25054825-25126057	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46688	15q11.2 population region (DGV_Gold_Standard_June_2021_gssvG12359)	15q11.2	chr15:20939772-20958971	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46687	15q13.2 population region (DGV_Gold_Standard_June_2021_gssvG12633)	15q13.2	chr15:30195894-30503867	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46686	15q11.2 population region (DGV_Gold_Standard_June_2021_gssvG12224)	15q11.2	chr15:20183488-22002386	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46685	14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12150)	14q32.33	chr14:106349168-106358775	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46684	14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12133)	14q32.33	chr14:106691149-106708515	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46683	14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12117)	14q32.33	chr14:106370520-106394986	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46682	14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12097)	14q32.33	chr14:105651840-105679437	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46681	14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10899)	14q11.2	chr14:18685852-18693371	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46680	14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10827)	14q11.2	chr14:19867377-19955139	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46679	14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10817)	14q11.2	chr14:19722070-19958650	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46678	14q11.2 population region (DGV_Gold_Standard_June_2021_gssvL33520)	14q11.2	chr14:19722540-19957072	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46677	14q11.2 population region (DGV_Gold_Standard_June_2021_gssvL33589)	14q11.2	chr14:18685827-18693395	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46676	14q13.2 population region (DGV_Gold_Standard_June_2021_gssvL34350)	14q13.2	chr14:35136190-35146114	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46675	14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10810)	14q11.2	chr14:19010800-19832182	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46674	14q32.33 population region (DGV_Gold_Standard_June_2021_gssvL37239)	14q32.33	tbd	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46673	14q32.33 population region (DGV_Gold_Standard_June_2021_gssvL37313)	14q32.33	chr14:106717601-106728149	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46672	13q12.11 population region (DGV_Gold_Standard_June_2021_gssvG9718)	13q12.11	chr13:20960774-20966984	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46671	13q21.33 population region (DGV_Gold_Standard_June_2021_gssvL31119)	13q21.33	chr13:71902850-71915649	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46670	13q21.1 population region (DGV_Gold_Standard_June_2021_gssvL30434)	13q21.1	chr13:57194374-57212808	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46669	12p13.31 population region (DGV_Gold_Standard_June_2021_gssvG7850)	12p13.31	chr12:8208926-8239193	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46668	12p13.31 population region (DGV_Gold_Standard_June_2021_gssvG7792)	12p13.31	chr12:8405494-8443619	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46667	12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23179)	12p13.2	chr12:10428652-10444444	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46666	12q23.3 population region (DGV_Gold_Standard_June_2021_gssvL26928)	12q23.3	chr12:104975237-104980402	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46665	12p11.1 population region (DGV_Gold_Standard_June_2021_gssvL24290)	12p11.1	chr12:34202958-34208608	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46664	12p11.23 population region (DGV_Gold_Standard_June_2021_gssvL23860)	12p11.23	chr12:27495007-27501798	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46663	12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23231)	12p13.2	chr12:11072385-11088297	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46662	12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23228)	12p13.2	chr12:11074482-11098540	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46661	12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23223)	12p13.2	chr12:11039082-11065026	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46660	11q12.2 population region (DGV_Gold_Standard_June_2021_gssvG6800)	11q12.2	chr11:61198674-61252927	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46659	11p14.1 population region (DGV_Gold_Standard_June_2021_gssvG6305)	11p14.1	chr11:28985603-28990540	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46658	11p15.1 population region (DGV_Gold_Standard_June_2021_gssvG6192)	11p15.1	chr11:18918658-18942110	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46657	11p15.4 population region (DGV_Gold_Standard_June_2021_gssvG5957)	11p15.4	chr11:4234735-4257233	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46656	11p15.4 population region (DGV_Gold_Standard_June_2021_gssvG5919)	11p15.4	chr11:3218081-3339758	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46655	11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16784)	11p15.4	chr11:4947458-4959002	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46654	11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16737)	11p15.4	chr11:4234219-4256896	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46653	11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16732)	11p15.4	chr11:4242862-4288500	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46652	11p15.5 population region (DGV_Gold_Standard_June_2021_gssvL16511)	11p15.5	chr11:1894015-1915772	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46651	11p15.1 population region (DGV_Gold_Standard_June_2021_gssvL17400)	11p15.1	chr11:18920312-18943051	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46650	11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16961)	11p15.4	chr11:7788205-7813338	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46649	11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16881)	11p15.4	chr11:5852754-5862269	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46648	11q22.2 population region (DGV_Gold_Standard_June_2021_gssvL21098)	11q22.2	chr11:102880376-102882132	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46647	11q13.4 population region (DGV_Gold_Standard_June_2021_gssvL19865)	11q13.4	chr11:72139602-72178286	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46646	11q11 population region (DGV_Gold_Standard_June_2021_gssvL19045)	11q11	chr11:55666777-55676508	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46645	11q11 population region (DGV_Gold_Standard_June_2021_gssvL19042)	11q11	chr11:55678233-55690300	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46644	10q22.1 population region (DGV_Gold_Standard_June_2021_gssvL13249)	10q22.1	chr10:69523150-69531336	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46643	10q22.1 population region (DGV_Gold_Standard_June_2021_gssvL13247)	10q22.1	chr10:69521059-69531547	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46642	10q11.22 population region (DGV_Gold_Standard_June_2021_gssvL12112)	10q11.22	chr10:47502722-47586882	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46641	10q11.23 population region (DGV_Gold_Standard_June_2021_gssvL12109)	10q11.23	chr10:50101946-50240976	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46640	10q11.22 population region (DGV_Gold_Standard_June_2021_gssvL12105)	10q11.22	chr10:47074765-47282602	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46639	10q11.22 population region (DGV_Gold_Standard_June_2021_gssvG4512)	10q11.22	chr10:46160527-46226532	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46638	10p12.1 population region (DGV_Gold_Standard_June_2021_gssvL11273)	10p12.1	chr10:27349327-27353251	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46637	10p13 population region (DGV_Gold_Standard_June_2021_gssvL10668)	10p13	chr10:13217247-13218742	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46636	9q32 population region (DGV_Gold_Standard_June_2021_gssvG40321)	9q32	chr9:114316520-114335867	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46635	9p11.2 population region (DGV_Gold_Standard_June_2021_gssvG38779)	9p11.2	chr9:42606667-43163949	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46634	9p12 population region (DGV_Gold_Standard_June_2021_gssvL130637)	9p12	chr9:61230528-61334753	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46633	9p12 population region (DGV_Gold_Standard_June_2021_gssvL130619)	9p12	chr9:66946498-67116738	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46632	9q31.1 population region (DGV_Gold_Standard_June_2021_gssvL132495)	9q31.1	chr9:104600434-104606341	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46631	8p23.1 population region (DGV_Gold_Standard_June_2021_gssvG36644)	8p23.1	chr8:7355060-7369899	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46630	8p23.1 population region (DGV_Gold_Standard_June_2021_gssvG36608)	8p23.1	chr8:6971214-7020634	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46629	8p23.1 population region (DGV_Gold_Standard_June_2021_gssvG36607)	8p23.1	chr8:7253423-7300285	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46628	7q36.1 population region (DGV_Gold_Standard_June_2021_gssvL119849)	7q36.1	chr7:150589058-150610821	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46627	7q35 population region (DGV_Gold_Standard_June_2021_gssvL119429)	7q35	chr7:144183522-144378826	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46626	7q35 population region (DGV_Gold_Standard_June_2021_gssvG35898)	7q35	chr7:144187118-144233372	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46625	7q22.1 population region (DGV_Gold_Standard_June_2021_gssvL117874)	7q22.1	chr7:102328550-102381792	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46624	7q34 population region (DGV_Gold_Standard_June_2021_gssvL119381)	7q34	chr7:142753425-142767072	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46623	7q34 population region (DGV_Gold_Standard_June_2021_gssvL119380)	7q34	chr7:142752325-142774385	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46622	7q34 population region (DGV_Gold_Standard_June_2021_gssvL119369)	7q34	tbd	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46621	7q34 population region (DGV_Gold_Standard_June_2021_gssvL119360)	7q34	tbd	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46620	7q11.23 population region (DGV_Gold_Standard_June_2021_gssvL116711)	7q11.23	chr7:74963584-75065983	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46619	7q11.21 population region (DGV_Gold_Standard_June_2021_gssvL116036)	7q11.21	chr7:63502788-63519014	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46618	7q11.21 population region (DGV_Gold_Standard_June_2021_gssvL115987)	7q11.21	chr7:63226937-63263270	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46617	7p11.2 population region (DGV_Gold_Standard_June_2021_gssvL115697)	7p11.2	chr7:56995057-57020978	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46616	7p14.1 population region (DGV_Gold_Standard_June_2021_gssvL115094)	7p14.1	chr7:38346962-38358142	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46615	7p22.1 population region (DGV_Gold_Standard_June_2021_gssvL113541)	7p22.1	chr7:6861142-6883612	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46614	6q13 population region (DGV_Gold_Standard_June_2021_gssvG32691)	6q13	chr6:73999168-74007298	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46613	6q13 population region (DGV_Gold_Standard_June_2021_gssvG32688)	6q13	chr6:73998109-74008782	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46612	6p25.3 population region (DGV_Gold_Standard_June_2021_gssvL104460)	6p25.3	chr6:83824-202184	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46611	6p21.32 population region (DGV_Gold_Standard_June_2021_gssvL106271)	6p21.32	chr6:32659773-32680646	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46610	6p21.32 population region (DGV_Gold_Standard_June_2021_gssvL106269)	6p21.32	chr6:32549059-32573916	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46609	6p21.32 population region (DGV_Gold_Standard_June_2021_gssvL106264)	6p21.32	chr6:32508079-32546462	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46608	6p22.1 population region (DGV_Gold_Standard_June_2021_gssvL105927)	6p22.1	chr6:29869423-29881496	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46607	6p22.1 population region (DGV_Gold_Standard_June_2021_gssvL105924)	6p22.1	chr6:29924783-29938057	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46605	5q13.2 population region (DGV_Gold_Standard_June_2021_gssvG30124)	5q13.2	chr5:70020257-70047833	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46604	5p15.33 population region (DGV_Gold_Standard_June_2021_gssvG29169)	5p15.33	chr5:814331-825252	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-05		
ISCA-46602	5q22.1 population region (DGV_Gold_Standard_June_2021_gssvL101506)	5q22.1	chr5:111570233-111575342	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46601	5q35.3 population region (DGV_Gold_Standard_June_2021_gssvL104429)	5q35.3	chr5:181164001-181169624	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-05		
ISCA-46600	5q35.3 population region (DGV_Gold_Standard_June_2021_gssvL104164)	5q35.3	chr5:178921351-178926193	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46599	5q31.3 population region (DGV_Gold_Standard_June_2021_gssvL102648)	5q31.3	chr5:140717182-140724468	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46598	4p11 population region (DGV_Gold_Standard_June_2021_gssvG27527)	4p11	chr4:49487225-49522795	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46597	4p16.1 population region (DGV_Gold_Standard_June_2021_gssvG27165)	4p16.1	chr4:9416271-9455642	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46596	4p16.1 population region (DGV_Gold_Standard_June_2021_gssvL88361)	4p16.1	chr4:9485260-9514441	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46595	4p11 population region (DGV_Gold_Standard_June_2021_gssvL90109)	4p11	chr4:49175172-49247858	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46594	4q13.2 population region (DGV_Gold_Standard_June_2021_gssvL90978)	4q13.2	chr4:69269114-69404673	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46593	4q13.3 population region (DGV_Gold_Standard_June_2021_gssvL91223)	4q13.3	chr4:74416911-74457464	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46592	3q29 population region (DGV_Gold_Standard_June_2021_gssvG26791)	3q29	chr3:195649717-195766662	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46591	3p12.3 population region (DGV_Gold_Standard_June_2021_gssvL82434)	3p12.3	chr3:75518194-75532541	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46590	3p12.3 population region (DGV_Gold_Standard_June_2021_gssvL82397)	3p12.3	chr3:75373756-75595473	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46589	3q29 population region (DGV_Gold_Standard_June_2021_gssvL86947)	3q29	chr3:195653407-195742693	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46588	3q25.31 population region (DGV_Gold_Standard_June_2021_gssvL85294)	3q25.31	chr3:155760377-155780857	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46587	3q11.2 population region (DGV_Gold_Standard_June_2021_gssvL83307)	3q11.2	chr3:98168648-98200490	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46586	3q11.2 population region (DGV_Gold_Standard_June_2021_gssvL83303)	3q11.2	chr3:98159451-98204582	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46585	2q37.3 population region (DGV_Gold_Standard_June_2021_gssvL70815)	2q37.3	chr2:241930711-242070030	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46584	2q21.1 population region (DGV_Gold_Standard_June_2021_gssvL66075)	2q21.1	chr2:130036309-130065676	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46583	2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64514)	2p11.2	chr2:90121435-90124718	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46582	2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64458)	2p11.2	chr2:90005627-90022201	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46581	2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64445)	2p11.2	chr2:90210510-90237066	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46580	2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64421)	2p11.2	chr2:89159760-89213455	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46579	2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64418)	2p11.2	chr2:90005741-90063995	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46578	2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64414)	2p11.2	chr2:89967024-90013408	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46577	1q44 population region (DGV_Gold_Standard_June_2021_gssvL8958)	1q44	chr1:248592354-248595177	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46576	1q44 population region (DGV_Gold_Standard_June_2021_gssvL8766)	1q44	chr1:248593579-248634508	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46575	1q41 population region (DGV_Gold_Standard_June_2021_gssvL7905)	1q41	chr1:222199866-222208120	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46574	1q24.2 population region (DGV_Gold_Standard_June_2021_gssvL5980)	1q24.2	chr1:168055320-168056494	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46573	1q23.3 population region (DGV_Gold_Standard_June_2021_gssvL5778)	1q23.3	chr1:161600533-161628390	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46572	1q21.3 population region (DGV_Gold_Standard_June_2021_gssvL5433)	1q21.3	chr1:152582450-152602872	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46571	1q21.2 population region (DGV_Gold_Standard_June_2021_gssvL5166)	1q21.2	chr1:143713202-143723502	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46570	1q21.2 population region (DGV_Gold_Standard_June_2021_gssvL5133)	1q21.2	chr1:143657400-143709403	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46569	1q21.2 population region (DGV_Gold_Standard_June_2021_gssvL5122)	1q21.2	chr1:148383996-148441436	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46568	1p31.3 population region (DGV_Gold_Standard_June_2021_gssvL3013)	1p31.3	chr1:64374229-64386185	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46567	1p31.3 population region (DGV_Gold_Standard_June_2021_gssvL2940)	1p31.3	chr1:62188989-62191539	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46566	1p36.12 population region (DGV_Gold_Standard_June_2021_gssvL1420)	1p36.12	chr1:21986630-22009219	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46565	1p36.13 population region (DGV_Gold_Standard_June_2021_gssvL1195)	1p36.13	chr1:16682950-16686282	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46564	1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL1109)	1p36.21	chr1:15826172-15829022	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46563	1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL1108)	1p36.21	chr1:15825195-15829107	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46562	1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL905)	1p36.21	chr1:12839542-12864430	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46561	1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL891)	1p36.21	chr1:12826782-12882210	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46560	1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL889)	1p36.21	chr1:13366389-13447984	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46559	1q21.3 population region (DGV_Gold_Standard_June_2021_gssvG2465)	1q21.3	chr1:152789019-152801061	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46558	1p13.3 population region (DGV_Gold_Standard_June_2021_gssvG1423)	1p13.3	chr1:108374690-108457706	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46557	1p36.21 population region (DGV_Gold_Standard_June_2021_gssvG371)	1p36.21	chr1:12837756-12862385	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46556	1p36.33 population region (DGV_Gold_Standard_June_2021_gssvG23)	1p36.33	chr1:777659-820629	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46554	1p36.33 population region ((DGV_Gold_Standard_June_2021_gssvG23))	1p36.33	chr1:777659-820629	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46553	3q24 Region (includes ZIC1)	3q24	chr3:136684193-148623326	3	Sufficient evidence for dosage pathogenicity	15338008	21204220	21471554	28503614	22067867		0	No evidence available							2021-07-19		
ISCA-46552	Yq11.223 population region (gnomAD-SV_v2.1_DUP_Y_55057)	Yq11.223	chrY:21878052-21923853	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46551	Yq11.223 population region (gnomAD-SV_v2.1_DUP_Y_55049)	Yq11.223	chrY:21495113-21551414	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46550	Xq28 population region (gnomAD-SV_v2.1_DEL_X_190964)	Xq28	chrX:156008634-156019835	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46549	Xq28 population region (gnomAD-SV_v2.1_DEL_X_190749)	Xq28	chrX:154246526-154256527	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46548	Xq28 population region (gnomAD-SV_v2.1_DEL_X_190688)	Xq28	chrX:153072616-153082817	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46547	Xq26.3 population region (gnomAD-SV_v2.1_DEL_X_189893)	Xq26.3	chrX:135831689-135847890	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46546	Xq26.3 population region (gnomAD-SV_v2.1_DEL_X_189886)	Xq26.3	chrX:135779496-135786197	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46545	Xq24 population region (gnomAD-SV_v2.1_DEL_X_189263)	Xq24	chrX:120943262-120986146	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46544	Xq24 population region (gnomAD-SV_v2.1_DEL_X_189262)	Xq24	tbd	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46543	Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53157)	Xp11.23	chrX:49574396-49592297	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46542	Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53155)	Xp11.23	chrX:49564396-49578797	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46541	Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53151)	Xp11.23	chrX:49528396-49554047	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46540	Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53149)	Xp11.23	chrX:49331318-49342419	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-03		
ISCA-46539	Xp11.23 population region (gnomAD-SV_v2.1_DEL_X_186156)	Xp11.23	chrX:49319820-49329571	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46538	22q13.1 population region (gnomAD-SV_v2.1_DEL_22_182715)	22q13.1	chr22:38962303-38992410	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46537	22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181682)	22q11.23	tbd	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46536	22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181680)	22q11.23	chr22:23982108-23992009	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46535	22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181679)	22q11.23	chr22:23973810-23980811	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46534	22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181670)	22q11.23	chr22:23931956-23969110	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46533	22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181532)	22q11.21	chr22:21207910-21215111	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46532	22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181459)	22q11.21	chr22:21324131-21329132	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46531	22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181452)	22q11.21	chr22:18601732-18607733	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46530	22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181446)	22q11.21	chr22:18516557-18521633	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46529	22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181316)	22q11.21	chr22:18751086-18759487	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46528	21q22.3 population region (gnomAD-SV_v2.1_DEL_21_181010)	21q22.3	chr21:46161013-46162994	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46527	21q11.2 population region (gnomAD-SV_v2.1_DEL_21_178683)	21q11.2	chr21:13640478-13662379	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46526	21q11.2 population region (gnomAD-SV_v2.1_DEL_21_178682)	21q11.2	chr21:13622878-13628879	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46525	21q11.2 population region (gnomAD-SV_v2.1_DEL_21_178681)	21q11.2	chr21:13608078-13613779	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46524	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173817)	19q13.42	chr19:54856544-54861645	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46523	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173816)	19q13.42	chr19:54849044-54858545	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46522	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173812)	19q13.42	chr19:54803444-54812145	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46521	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173811)	19q13.42	chr19:54790047-54812548	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46520	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173809)	19q13.42	chr19:54781547-54786548	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46519	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173807)	19q13.42	chr19:54774547-54781548	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-03		
ISCA-46518	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173806)	19q13.42	chr19:54766547-54776548	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46517	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173805)	19q13.42	chr19:54763397-54770148	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46516	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173803)	19q13.42	chr19:54745547-54777548	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46515	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173802)	19q13.42	chr19:54740153-54745554	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46514	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173801)	19q13.42	chr19:54739307-54755684	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46513	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173800)	19q13.42	chr19:54734133-54739234	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46512	19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173749)	19q13.42	chr19:54297004-54303769	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46511	19q13.41 population region (gnomAD-SV_v2.1_DEL_19_173549)	19q13.41	chr19:52812971-52820472	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46510	19q13.41 population region (gnomAD-SV_v2.1_DEL_19_173445)	19q13.41	chr19:51631046-51645747	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46509	19q13.41 population region (gnomAD-SV_v2.1_DEL_19_173443)	19q13.41	chr19:51624746-51636147	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46508	19q13.31 population region (gnomAD-SV_v2.1_DEL_19_172626)	19q13.31	chr19:43196847-43211848	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46507	19q13.31 population region (gnomAD-SV_v2.1_DEL_19_172625)	19q13.31	chr19:43196814-43260657	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46506	19q13.12 population region (gnomAD-SV_v2.1_DEL_19_172006)	19q13.12	chr19:35360097-35372373	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46505	19p13.2 population region (gnomAD-SV_v2.1_DUP_19_46817)	19p13.2	chr19:7019163-7060489	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46504	17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160670)	17q21.31	chr17:46560633-46575634	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46503	17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160664)	17q21.31	chr17:46326533-46332534	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46502	17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160663)	17q21.31	chr17:46323833-46341084	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46501	17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160662)	17q21.31	chr17:46321733-46328334	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46500	17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160659)	17q21.31	chr17:46304333-46309634	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46499	17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160658)	17q21.31	chr17:46291633-46302634	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46498	17q21.2 population region (gnomAD-SV_v2.1_DUP_17_44064)	17q21.2	chr17:41375714-41383037	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46497	17q21.2 population region (gnomAD-SV_v2.1_DEL_17_160290)	17q21.2	chr17:41265541-41275893	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46496	17q21.2 population region (gnomAD-SV_v2.1_DEL_17_160287)	17q21.2	chr17:41227747-41238748	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46495	17p11.2 population region (gnomAD-SV_v2.1_DEL_17_159095)	17p11.2	chr17:19111686-19150687	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46494	17p11.2 population region (gnomAD-SV_v2.1_DEL_17_159047)	17p11.2	chr17:18426684-18561836	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46493	16q22.1 population region (gnomAD-SV_v2.1_DUP_16_42449)	16q22.1	chr16:70060340-70209053	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46492	16p11.2 population region (gnomAD-SV_v2.1_DEL_16_153860)	16p11.2	chr16:32644678-32790679	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46491	16p11.2 population region (gnomAD-SV_v2.1_DUP_16_42022)	16p11.2	chr16:32008678-32084679	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-04		
ISCA-46490	16p11.2 population region (gnomAD-SV_v2.1_DEL_16_153573)	16p11.2	chr16:28753678-28760679	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46489	16p11.2 population region (gnomAD-SV_v2.1_DEL_16_153568)	16p11.2	chr16:28703778-28759679	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-04		
ISCA-46488	16p12.3 population region (gnomAD-SV_v2.1_DEL_16_152900)	16p12.3	chr16:18321142-18327143	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46487	16p13.11 population region (gnomAD-SV_v2.1_DEL_16_152730)	16p13.11	chr16:16235742-16270493	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-23		
ISCA-46485	16p13.12 population region (gnomAD-SV_v2.1_DEL_16_152600)	16p13.12	chr16:14689142-14759293	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46484	16p13.12 population region (gnomAD-SV_v2.1_DEL_16_152599)	16p13.12	chr16:14688342-14711143	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46483	16p13.3 population region (gnomAD-SV_v2.1_DEL_16_151010)	16p13.3	tbd	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46482	15q14 population region (gnomAD-SV_v2.1_DEL_15_146739)	15q14	chr15:34434156-34580684	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46481	15q14 population region (gnomAD-SV_v2.1_DEL_15_146738)	15q14	chr15:34417925-34564356	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46480	15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146627)	15q13.3	chr15:32593998-32605799	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46479	15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146625)	15q13.3	chr15:32572798-32605799	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46478	15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146614)	15q13.3	chr15:32482798-32487799	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46477	15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146612)	15q13.3	chr15:32451798-32462899	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46476	15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146609)	15q13.3	chr15:32400798-32405799	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46475	15q13.3 population region (gnomAD-SV_v2.1_DUP_15_39790)	15q13.3	chr15:32398573-32442049	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-09		
ISCA-46474	15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146467)	15q13.2	chr15:30555746-30590897	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46473	15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146464)	15q13.2	chr15:30532996-30560897	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46472	15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146452)	15q13.2	chr15:30400796-30432997	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46471	15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146453)	15q13.2	chr15:30140795-30590897	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46470	15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146428)	15q13.2	chr15:30089745-30146297	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46469	15q11.2 population region (gnomAD-SV_v2.1_DEL_15_145837)	15q11.2	chr15:20836720-20850971	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46468	15q11.2 population region (gnomAD-SV_v2.1_DEL_15_145826)	15q11.2	chr15:20523935-20540286	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46467	14q11.2 population region (gnomAD-SV_v2.1_DEL_14_140616)	14q11.2	chr14:23998790-24004791	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46466	12q12 population region (gnomAD-SV_v2.1_DEL_12_127735)	12q12	chr12:40480964-40482622	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46465	12p11.23 population region (gnomAD-SV_v2.1_DEL_12_126677)	12p11.23	chr12:27495208-27502230	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46464	12p13.2 population region (gnomAD-SV_v2.1_DEL_12_125610)	12p13.2	chr12:11073400-11098001	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46463	12p13.2 population region (gnomAD-SV_v2.1_DEL_12_125568)	12p13.2	chr12:10429000-10435076	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46462	12p13.2 population region (gnomAD-SV_v2.1_DEL_12_125567)	12p13.2	chr12:10428945-10444404	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46461	12p13.31 population region (gnomAD-SV_v2.1_DUP_12_33971)	12p13.31	chr12:8208853-8238300	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-09		
ISCA-46460	11q14.3 population region (gnomAD-SV_v2.1_DEL_11_121860)	11q14.3	chr11:90029831-90050232	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46459	11q14.3 population region (gnomAD-SV_v2.1_DUP_11_33042)	11q14.3	chr11:89786909-89923863	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-09		
ISCA-46458	11q11 population region (gnomAD-SV_v2.1_DEL_11_119564)	11q11	chr11:55596799-55676539	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46457	11q11 population region (gnomAD-SV_v2.1_DEL_11_119505)	11q11	chr11:55264126-55271064	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-09		
ISCA-46456	11p15.4 population region (gnomAD-SV_v2.1_DEL_11_116241)	11p15.4	chr11:7789628-7811831	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46455	11p15.4 population region (gnomAD-SV_v2.1_DEL_11_116124)	11p15.4	chr11:5852758-5862263	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46454	11p15.4 population region (gnomAD-SV_v2.1_DEL_11_116046)	11p15.4	chr11:4946516-4955428	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46453	10q22.3 population region (gnomAD-SV_v2.1_DEL_10_112166)	10q22.3	chr10:79844743-79851044	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46452	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110230)	10q11.23	chr10:50213439-50221540	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46451	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110229)	10q11.23	chr10:50207439-50214640	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46450	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110225)	10q11.23	chr10:50102239-50134890	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46449	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110224)	10q11.23	chr10:50098539-50104840	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46448	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110223)	10q11.23	chr10:50092089-50097640	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46447	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110222)	10q11.23	chr10:50085939-50091040	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46446	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110221)	10q11.23	chr10:50079939-50085340	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46445	10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110193)	10q11.23	chr10:73668724-73680225	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46444	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110072)	10q11.22	chr10:46933236-46939112	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46443	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110044)	10q11.22	chr10:47487361-47493362	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46442	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110043)	10q11.22	chr10:47499361-47507162	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46441	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110040)	10q11.22	chr10:46798971-46848972	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46440	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110031)	10q11.22	chr10:50205831-50224757	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46439	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110022)	10q11.22	chr10:50116898-50122299	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46438	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110021)	10q11.22	chr10:50111946-50119097	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46437	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110019)	10q11.22	chr10:50080601-50103402	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46436	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110016)	10q11.22	chr10:46377639-46383340	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46435	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110001)	10q11.22	chr10:48029382-48034483	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46434	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110000)	10q11.22	chr10:48009306-48019507	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46433	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109999)	10q11.22	chr10:46373069-46378170	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46432	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109998)	10q11.22	chr10:46377769-46382770	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46431	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109958)	10q11.22	chr10:45843151-45879552	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46430	10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109954)	10q11.22	chr10:45815201-45830352	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46429	10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108289)	10p12.33	chr10:17837946-17846047	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46428	10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108288)	10p12.33	chr10:17828846-17841147	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46427	10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108283)	10p12.33	chr10:17838000-17851801	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46426	10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108282)	10p12.33	chr10:17826000-17838001	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46425	9q34.3 population region (gnomAD-SV_v2.1_DEL_9_106704)	9q34.3	chr9:136045003-136052654	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46424	9q31.2 population region (gnomAD-SV_v2.1_DEL_9_104809)	9q31.2	chr9:107775253-107778314	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46423	9q21.11 population region (gnomAD-SV_v2.1_DUP_9_27462)	9q21.11	chr9:41373825-41397601	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-17		
ISCA-46422	9q21.11 population region (gnomAD-SV_v2.1_DUP_9_27460)	9q21.11	chr9:41447948-41584416	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-10		
ISCA-46421	9q21.11 population region (gnomAD-SV_v2.1_DEL_9_102461)	9q21.11	chr9:64406506-64422682	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46420	9q21.11 population region (gnomAD-SV_v2.1_DEL_9_102460)	9q21.11	chr9:64386331-64392782	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46419	9q21.11 population region (gnomAD-SV_v2.1_DEL_9_102459)	9q21.11	chr9:64363081-64375807	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46418	9q13 population region (gnomAD-SV_v2.1_DEL_9_102391)	9q13	chr9:67887053-67919054	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-10		
ISCA-46417	9q12 population region (gnomAD-SV_v2.1_DEL_9_102303)	9q12	chr9:39368304-39380305	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46416	9p11.1 population region (gnomAD-SV_v2.1_DEL_9_102297)	9p11.1	chr9:41901558-41912138	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46415	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102296)	9p11.2	chr9:41893458-41898459	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46414	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102294)	9p11.2	chr9:41875633-41894584	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46413	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102236)	9p11.2	chr9:67701487-67723488	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46412	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102187)	9p11.2	chr9:67724915-67742791	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46411	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102099)	9p11.2	chr9:42571218-42576319	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46410	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102097)	9p11.2	chr9:42579118-42598119	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46409	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102096)	9p11.2	chr9:42712222-42793523	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46408	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102085)	9p11.2	chr9:42657618-42675119	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46407	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102049)	9p11.2	chr9:67288703-67293954	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46406	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102048)	9p11.2	chr9:61055297-61066848	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46405	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102047)	9p11.2	chr9:61087440-61115941	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46404	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102046)	9p11.2	chr9:61087440-61092841	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46403	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102043)	9p11.2	chr9:67173745-67222796	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46402	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102042)	9p11.2	chr9:67168889-67177290	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46401	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102036)	9p11.2	chr9:67106870-67112071	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46400	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102035)	9p11.2	chr9:67097078-67112079	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46399	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102032)	9p11.2	chr9:67082041-67101042	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46398	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102027)	9p11.2	chr9:61192272-61211173	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46397	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102025)	9p11.2	chr9:61196784-61203785	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46396	9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102024)	9p11.2	chr9:61197782-61282783	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46395	9p12 population region (gnomAD-SV_v2.1_DEL_9_101967)	9p12	chr9:40218981-40229782	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46394	9p12 population region (gnomAD-SV_v2.1_DEL_9_101925)	9p12	chr9:60913727-60920728	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46393	9p12 population region (gnomAD-SV_v2.1_DEL_9_101915)	9p12	chr9:42187993-42193994	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46392	9p13.1 population region (gnomAD-SV_v2.1_DEL_9_101840)	9p13.1	chr9:67289628-67296529	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46391	9p24.3 population region (gnomAD-SV_v2.1_DUP_9_26178)	9p24.3	chr9:111999-126000	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-11		
ISCA-46390	8q24.3 population region (gnomAD-SV_v2.1_DEL_8_98285)	8q24.3	chr8:144256043-144278794	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46389	8q24.3 population region (gnomAD-SV_v2.1_DEL_8_98283)	8q24.3	chr8:144257946-144277497	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46388	8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89725)	8p23.1	chr8:12433690-12453541	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46387	8p23.1 population region (gnomAD-SV_v2.1_DUP_8_23819)	8p23.1	chr8:12394290-12439891	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-11		
ISCA-46386	8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89706)	8p23.1	chr8:12104490-12110491	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46385	8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89703)	8p23.1	chr8:12046490-12068491	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46384	8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89357)	8p23.1	chr8:7948727-7954578	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46383	8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89356)	8p23.1	chr8:7941477-7966578	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46382	8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89355)	8p23.1	chr8:7887477-7896578	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46381	8p23.1 population region (gnomAD-SV_v2.1_DUP_8_23708)	8p23.1	chr8:7879477-7885578	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-17		
ISCA-46380	8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89353)	8p23.1	chr8:7878977-7906978	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46379	8p23.3 population region (gnomAD-SV_v2.1_DEL_8_88408)	8p23.3	chr8:166099-179200	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46378	8p23.3 population region (gnomAD-SV_v2.1_DEL_8_88399)	8p23.3	chr8:75899-83100	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46377	7q35 population region (gnomAD-SV_v2.1_DEL_7_87112)	7q35	chr7:143711906-143720407	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46376	7q34 population region (gnomAD-SV_v2.1_DEL_7_87016)	7q34	chr7:142065624-142094699	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46375	7q34 population region (gnomAD-SV_v2.1_DEL_7_87015)	7q34	chr7:142055193-142081179	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-11		
ISCA-46374	7q22.1 population region (gnomAD-SV_v2.1_DEL_7_84412)	7q22.1	chr7:102660552-102690553	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46373	7q22.1 population region (gnomAD-SV_v2.1_DEL_7_84190)	7q22.1	chr7:99863767-99865939	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46372	7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82638)	7q11.23	chr7:75054892-75062193	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46371	7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82637)	7q11.23	chr7:75038895-75045096	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46370	7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82636)	7q11.23	chr7:75006833-75013834	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46369	7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82621)	7q11.23	chr7:74809162-74815663	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46368	7q11.21 population region (gnomAD-SV_v2.1_DEL_7_81890)	7q11.21	chr7:65646085-65679086	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46367	7p22.1 population region (gnomAD-SV_v2.1_DEL_7_77893)	7p22.1	chr7:6779368-6787569	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46366	7p22.1 population region (gnomAD-SV_v2.1_DEL_7_77769)	7p22.1	chr7:5937368-5942369	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46365	7p22.1 population region (gnomAD-SV_v2.1_DEL_7_77765)	7p22.1	chr7:5901368-5913369	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46364	5q35.3 population region (gnomAD-SV_v2.1_DEL_5_65880)	5q35.3	chr5:181360998-181429999	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46363	5q35.3 population region (gnomAD-SV_v2.1_DEL_5_65831)	5q35.3	chr5:180948131-181003626	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46362	5q31.3 population region (gnomAD-SV_v2.1_DEL_5_63328)	5q31.3	chr5:140842551-140859346	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46361	5q13.2 population region (gnomAD-SV_v2.1_DEL_5_58900)	5q13.2	chr5:71031172-71039873	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46360	5q13.2 population region (gnomAD-SV_v2.1_DUP_5_15442)	5q13.2	chr5:71028672-71108173	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-12		
ISCA-46359	5q13.2 population region (gnomAD-SV_v2.1_DEL_5_58897)	5q13.2	chr5:71017172-71069273	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46358	5q13.2 population region (gnomAD-SV_v2.1_DUP_5_15350)	5q13.2	chr5:70009572-70073273	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-12		
ISCA-46357	4q13.3 population region (gnomAD-SV_v2.1_DEL_4_46753)	4q13.3	chr4:74448523-74457524	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46356	4q13.3 population region (gnomAD-SV_v2.1_DEL_4_46744)	4q13.3	chr4:74450282-74457283	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46355	4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46404)	4q13.2	chr4:69286321-69395616	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46354	4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46401)	4q13.2	chr4:69272345-69381447	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46353	4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46399)	4q13.2	chr4:69260763-69369641	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46352	4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46398)	4q13.2	chr4:69258281-69305582	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46351	4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46396)	4q13.2	chr4:69257932-69366619	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46350	3p12.3 population region (gnomAD-SV_v2.1_DEL_3_33722)	3p12.3	chr3:75718848-75746849	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46349	2q21.2 population region (gnomAD-SV_v2.1_DUP_2_6167)	2q21.2	chr2:132096003-132455990	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46348	2q21.2 population region (gnomAD-SV_v2.1_DEL_2_22275)	2q21.2	chr2:131762426-131771427	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46347	2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22163)	2q21.1	chr2:130655226-130672427	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46346	2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22156)	2q21.1	chr2:130491326-130497027	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46345	2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22155)	2q21.1	chr2:130479426-130484427	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46344	2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22135)	2q21.1	chr2:130197365-130199814	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46343	2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22133)	2q21.1	chr2:130196426-130201427	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46342	2p11.2 population region (gnomAD-SV_v2.1_DEL_2_19888)	2p11.2	chr2:87015076-87026477	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46341	1q44 population region (gnomAD-SV_v2.1_DEL_1_13898)	1q44	chr1:248643398-248656424	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46340	1q44 population region (gnomAD-SV_v2.1_DEL_1_13890)	1q44	chr1:248574698-248580699	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46339	1q44 population region (gnomAD-SV_v2.1_DEL_1_13889)	1q44	chr1:248567698-248634899	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46338	1q44 population region (gnomAD-SV_v2.1_DEL_1_13888)	1q44	chr1:248565698-248579699	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46337	1q44 population region (gnomAD-SV_v2.1_DEL_1_13885)	1q44	chr1:248549153-248594102	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46336	1q44 population region (gnomAD-SV_v2.1_DUP_1_3816)	1q44	chr1:248456698-248483699	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46335	1q32.2 population region (gnomAD-SV_v2.1_DEL_1_11282)	1q32.2	chr1:207535404-207544705	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-16		
ISCA-46334	1q25.2 population region (gnomAD-SV_v2.1_DEL_1_9549)	1q25.2	chr1:179486462-179489161	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46333	1q23.3 population region (gnomAD-SV_v2.1_DEL_1_8646)	1q23.3	chr1:161559468-161641133	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46332	1q21.3 population region (gnomAD-SV_v2.1_DEL_1_8087)	1q21.3	chr1:152788043-152798615	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46331	1q21.3 population region (gnomAD-SV_v2.1_DEL_1_8075)	1q21.3	chr1:152583065-152615264	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46330	1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7863)	1q21.2	chr1:143902073-143911524	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46329	1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7859)	1q21.2	chr1:143874448-143938649	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46328	1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7798)	1q21.2	chr1:120900178-120910679	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46327	1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7795)	1q21.2	chr1:148459777-148510778	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46326	1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7781)	1q21.2	chr1:148087722-148158223	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46325	1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7778)	1q21.2	chr1:147961367-147982768	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46324	1q21.1 population region (gnomAD-SV_v2.1_DEL_1_7699)	1q21.1	chr1:147017931-147080932	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46323	1p13.3 population region (gnomAD-SV_v2.1_DEL_1_7022)	1p13.3	chr1:109687572-109711959	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46322	1p13.3 population region (gnomAD-SV_v2.1_DEL_1_6959)	1p13.3	chr1:108380727-108453478	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46321	1p21.1 population region (gnomAD-SV_v2.1_DUP_1_1884)	1p21.1	chr1:103648377-103760578	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46320	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1945)	1p36.11	chr1:25328508-25334859	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46319	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1944)	1p36.11	chr1:25317908-25323009	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46318	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1943)	1p36.11	chr1:25313008-25323509	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46317	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1941)	1p36.11	chr1:25304408-25309509	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46316	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1939)	1p36.11	chr1:25287508-25294509	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46315	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1938)	1p36.11	chr1:25267208-25283709	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46314	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1937)	1p36.11	chr1:25266308-25324509	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-17		
ISCA-46313	1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1834)	1p36.11	chr1:23957509-23964510	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-12		
ISCA-46312	1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1100)	1p36.21	chr1:13040162-13049863	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46311	1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1094)	1p36.21	chr1:12929369-12939070	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46310	1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1089)	1p36.21	chr1:12890169-12906170	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46309	1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1085)	1p36.21	chr1:12836571-12870422	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46308	1p36.21 population region (gnomAD-SV_v2.1_DUP_1_507)	1p36.21	chr1:12835148-12880149	0	No evidence available							40	Dosage sensitivity unlikely							2021-08-06		
ISCA-46307	1p36.33 population region (gnomAD-SV_v2.1_DEL_1_195)	1p36.33	chr1:1709560-1715561	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46306	1p36.33 population region (gnomAD-SV_v2.1_DEL_1_11)	1p36.33	chr1:455336-493087	40	Dosage sensitivity unlikely							0	No evidence available							2021-08-06		
ISCA-46304	Xq28 region (includes MECP2)	Xq28	chrX:154008529-154110279	0	No evidence available							3	Sufficient evidence for dosage pathogenicity	32043567	29618507	22679399	29141583			2021-02-22		300260
ISCA-46303	SOX9 upstream enhancer region	17q24.3	chr17:69896855-71796293	3	Sufficient evidence for dosage pathogenicity	19234473	26663529	24934569				1	Little evidence for dosage pathogenicity	32583964	19639023					2021-06-07	106995	261800
ISCA-46302	Xp21.2 region (includes NR0B1)	Xp21.2	chrX:30176883-30336883	0	No evidence available							3	Sufficient evidence for dosage pathogenicity	22518125	17504899	20685758				2020-07-22		300018
ISCA-46300	15q24 recurrent region (LCR C-LCR D) (includes SIN3A)	15q24	chr15:75339446-75680568	3	Sufficient evidence for dosage pathogenicity	27399968	22180641					0	No evidence available							2020-01-13	613406	
ISCA-46299	Xp11.22 region (includes HUWE1)	Xp11.22	chrX:53334251-53766556	0	No evidence available							3	Sufficient evidence for dosage pathogenicity	22840365	20655035	26692240				2018-11-19		
ISCA-46298	13q12.12 recurrent region (includes SACS, SGCG)	13q12.12	chr13:22970443-24307222	0	No evidence available	30767844						40	Dosage sensitivity unlikely							2021-04-26		
ISCA-46297	16p12.2 recurrent region (distal)(includes OTOA)	16p12.2	chr16:21558792-21729102	30	Gene associated with autosomal recessive phenotype							40	Dosage sensitivity unlikely							2019-11-03	607039	
ISCA-46296	15q24 recurrent region (LCR A-LCR C)	15q24.1-q24.2	chr15:72671374-75215971	3	Sufficient evidence for dosage pathogenicity	22180641	19921647					1	Little evidence for dosage pathogenicity	19557438	20860070					2020-01-03		
ISCA-46295	15q13.3 recurrent region (D-CHRNA7 to BP5) (includes CHRNA7, OTUD7A)	15q13.3	chr15:31727418-32153204	3	Sufficient evidence for dosage pathogenicity	19898479	20236110	22775350				40	Dosage sensitivity unlikely	26968334	22420048					2018-05-10		
ISCA-46291	7q11.23 recurrent distal region (includes HIP1, YWHAG)	7q11.23	chr7:75528718-76433859	2	Some evidence for dosage pathogenicity	21109226	16971481					1	Little evidence for dosage pathogenicity	21109226	27867344					2018-12-31		
ISCA-46290	Xp11.22p11.23 recurrent region (includes SHROOM4)	Xp11.22-p11.23	chrX:48447780-52444264	0	No evidence available							3	Sufficient evidence for dosage pathogenicity	19716111	21418194	25425167				2017-12-14		300801
ISCA-46288	2q21.1 recurrent region (includes ARHGEF4, GPR148)	2q21.1	chr2:130719936-131172120	1	Little evidence for dosage pathogenicity	22543972	24591035	25661985				0	No evidence available	22543972						2019-09-30		
ISCA-46287	2p24.3 MYCN-DDX1 duplication region	2p24.3	chr2:15568553-16045215									2	Some evidence for dosage pathogenicity	27794475	24161495	23401364				2017-08-07		
ISCA-46285	15q13 recurrent region (BP3-BP4) (includes APBA2)	15q13.1-q13.2	chr15:28916886-30076787	0	No evidence available	21248749	19372089	18278044				0	No evidence available							2020-03-09		
ISCA-37516	22q11.2 recurrent region (central, B/C-D) (includes CRKL)	22q11.21	chr22:20377696-21111383	2	Some evidence for dosage pathogenicity	25123976	22893440	26278718				1	Little evidence for dosage pathogenicity	22796526	18414210	19490635				2017-09-14		
ISCA-37514	15q25.2q25.3 recurrent region (distal, LCR C-LCR D)	15q25.2-q25.3	chr15:84596421-85169770	1	Little evidence for dosage pathogenicity	23239641						0	No evidence available							2020-06-26		
ISCA-37501	17q23.1q23.2 recurrent region (includes TBX2, TBX4)	17q23.1-q23.2	chr17:60035641-62198448	3	Sufficient evidence for dosage pathogenicity	20206336	22052739					2	Some evidence for dosage pathogenicity	20598276	24592505					2018-11-19	613355	
ISCA-37500	15q25.2 recurrent region (proximal LCR B-LCR C)	15q25.2	chr15:82534140-84045981	3	Sufficient evidence for dosage pathogenicity	24352913	23166063	17847001				0	No evidence available							2016-10-13	614294	
ISCA-37498	11q13.2q13.4 recurrent region (includes SHANK2, FGFs)	11q13.2-q13.4	chr11:67996175-71525885	2	Some evidence for dosage pathogenicity	21373257	28211979					0	No evidence available							2018-01-26		
ISCA-37496	2q13 recurrent region (includes BCL2L11)	2q13	chr2:110634616-112347165	2	Some evidence for dosage pathogenicity	26227573	26236398	21255006				2	Some evidence for dosage pathogenicity	26227573	24807792	21255006				2018-06-22		
ISCA-37495	2q11.2 recurrent region (includes ARID5A, LMAN2L)	2q11.2	chr2:96073264-97005692	1	Little evidence for dosage pathogenicity	26227573	19443486					1	Little evidence for dosage pathogenicity	26227573	19443486					2020-02-28		
ISCA-37494	Xq28 recurrent region (int22h1/int22h2-flanked) (includes RAB39B)	Xq28	chrX:154890328-155335092	3	Sufficient evidence for dosage pathogenicity	25927380	21984752					3	Sufficient evidence for dosage pathogenicity	25927380	21984752	24357492				2018-08-30		300815
ISCA-37493	1q43q44 terminal region (includes AKT3)	1q43-q44	chr1:243124428-245154985	3	Sufficient evidence for dosage pathogenicity	17603806	21800092	22678713				0	No evidence available	23794269						2016-10-12	612337	
ISCA-37486	16p11.2 recurrent region (distal, BP2-BP3) (includes SH2B1)	16p11.2	chr16:28811314-29035178	3	Sufficient evidence for dosage pathogenicity	20808231	19966786	23258348				1	Little evidence for dosage pathogenicity	27240531	23258348					2017-03-09	613444	
ISCA-37483	19q13.3 region (PSG gene cluster)	19q13	chr19:42738644-43237158	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2014-03-13		
ISCA-37481	3 copies: 16p centromere	16p11.1	chr16:34967717-35913137	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2013-08-01		
ISCA-37480	3 copies: 15q telomere	15q26.3	chr15:101621277-101981189	0	No evidence available							40	Dosage sensitivity unlikely							2013-11-26		
ISCA-37478	15q11.2q13 recurrent (PWS/AS) region (Class 2,BP2-BP3)	15q11.2-q13.1	chr15:23465365-28134728	3	Sufficient evidence for dosage pathogenicity	7611294	22045295					3	Sufficient evidence for dosage pathogenicity	9106540	18374305	16840569				2013-11-26	176270	608636
ISCA-37477	1 copy: 14q telomere; 3 copies: 14q telomere	14q32.3	chr14:105583663-106881350	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2014-07-31		
ISCA-37476	14q11.2 region (TCRA region)	14q11.2	chr14:21642889-22552154	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2015-04-09		
ISCA-37472	8p23.1 region (DEFB gene cluster)	8p23.1	chr8:7195664-8273167	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2014-03-12		
ISCA-37471	1 copy: 6p telomere | 3 copies: 6p telomere	6p25	chr6:259528-339802	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2014-06-20		
ISCA-37470	1 copy: 2q telomere|3 copies: 2q telomere	2q37.3	chr2:241988449-242157305	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2014-04-24		
ISCA-37469	1q21.2 region (polymorphic region)(non-unique; also maps to chromosomes 16, 7, and others in GRCh38)	1q21.2	chr16:34632766-36224317	40	Dosage sensitivity unlikely							40	Dosage sensitivity unlikely							2020-10-22		
ISCA-37468	Xp11.23 region (includes MAOA and MAOB)	Xp11.23	chrX:43654906-43882474	3	Sufficient evidence for dosage pathogenicity	22365943	20485326	23414621				0	No evidence available							2017-10-11		
ISCA-37467	7q36.3 ZRS (SHH cis-regulatory) duplication region (within LMBR1 intron 5)	7q36.3	chr7:156791102-156791874	0	No evidence available							3	Sufficient evidence for dosage pathogenicity	18178630	18417549	19291772				2018-02-14		174500
ISCA-37449	14q32 region associated with UPD(14) phenotypes	14q32	chr14:99928257-101038192	2	Some evidence for dosage pathogenicity	20179077	18454453					0	No evidence available							2012-05-10	608149	
ISCA-37448	15q11.2 recurrent region (BP1-BP2) (includes NIPA1)	15q11.2	chr15:22782170-23040134	3	Sufficient evidence for dosage pathogenicity	31451536	24352232	30767844	31665216			40	Dosage sensitivity unlikely							2021-04-12		
ISCA-37447	DLK1-MEG3 Intergenic DMR	14q32.2	chr14:100725054-100828279	1	Little evidence for dosage pathogenicity	20585555						0	No evidence available							2012-05-10	608149	
ISCA-37446	22q11.2 recurrent (DGS/VCFS) region (proximal, A-D) (includes TBX1)	22q11.21	chr22:18924718-21111383	3	Sufficient evidence for dosage pathogenicity	20301696	27189754					3	Sufficient evidence for dosage pathogenicity	20301749	19254783	18414210				2018-08-31	188400	608363
ISCA-37443	3q29 recurrent region (includes DLG1)	3q29	chr3:196029183-197617791	3	Sufficient evidence for dosage pathogenicity							2	Some evidence for dosage pathogenicity	18241066	18471269	24838842				2016-01-21	609425	611936
ISCA-37442	6q24 region (includes PLAGL1)	6q24	chr6:143922155-144095424	1	Little evidence for dosage pathogenicity	16971482						3	Sufficient evidence for dosage pathogenicity	10615957	8842729	10923638				2016-05-24		601410
ISCA-37441	11p11.2 (Potocki-Shaffer syndrome) region (includes ALX4, EXT2)	11p11.2	chr11:43873250-46130899	3	Sufficient evidence for dosage pathogenicity	15852040	16319823	20140962				0	No evidence available							2013-12-12	601224	
ISCA-37440	2p21 region (includes PREPL and SLC3A1)	2p21	chr2:44183133-44362502	30	Gene associated with autosomal recessive phenotype	11524703	16385448	18234729				0	No evidence available							2012-03-21	606407	
ISCA-37439	Xq28 recurrent region (includes GDI1)	Xq28	chrX:154396223-154555683	0	No evidence available							3	Sufficient evidence for dosage pathogenicity	20004760	17546640	18047645				2016-05-26		300815
ISCA-37438	14q11.2 region including CHD8 and SUPT16H	14q11.2	chr14:21358741-21393828	2	Some evidence for dosage pathogenicity	17545556						0	No evidence available							2012-05-09		
ISCA-37436	17p12 recurrent (HNPP/CMT1A) region (includes PMP22)	17p12	chr17:14194598-15519638	3	Sufficient evidence for dosage pathogenicity	20301566						3	Sufficient evidence for dosage pathogenicity	20301384						2016-10-13	162500	118220
ISCA-37434	1p36 terminal region (includes GABRD)	1p36.33-p36.31	chr1:898703-6229913	3	Sufficient evidence for dosage pathogenicity	17918734	18245432	22766398				2	Some evidence for dosage pathogenicity							2016-05-31	607872	
ISCA-37433	22q11.2 recurrent (DGS/VCFS) region (proximal, A-B) (includes TBX1)	22q11.21	chr22:18924718-20299685	3	Sufficient evidence for dosage pathogenicity	20301696	27189754	26278718				3	Sufficient evidence for dosage pathogenicity	20301749	19254783	18414210				2018-08-31	188400	608363
ISCA-37432	17q12 recurrent (RCAD syndrome) region (includes HNF1B)	17q12	chr17:36458167-37854616	3	Sufficient evidence for dosage pathogenicity							3	Sufficient evidence for dosage pathogenicity							2015-08-10	614527	614526
ISCA-37431	17q11.2 recurrent region (includes NF1)	17q11.2	chr17:30780079-31937008	3	Sufficient evidence for dosage pathogenicity	20513137	20543202	22151963				2	Some evidence for dosage pathogenicity	22241097	18183042	25205021				2020-10-12	613675	618874
ISCA-37430	17p13.3 (Miller-Dieker syndrome) region (includes YWHAE and PAFAH1B1)	17p13.3	chr17:1344539-2685615	3	Sufficient evidence for dosage pathogenicity	3391613, 1671808,  1879837,  7634541, 19584063, 12621583						3	Sufficient evidence for dosage pathogenicity	19136950	19520700	23813913				2016-11-09	247200	613215
ISCA-37429	4p16.3 terminal (Wolf-Hirschhorn syndrome) region	4p16.3	chr4:337779-2009235	3	Sufficient evidence for dosage pathogenicity							2	Some evidence for dosage pathogenicity							2016-08-11	194190	
ISCA-37428	1q21.1 recurrent (TAR syndrome) region (proximal, BP2-BP3) (includes RBM8A)	1q21.1	chr1:145686999-146048495	1	Little evidence for dosage pathogenicity	22317977	25217958					1	Little evidence for dosage pathogenicity	22317977	25217958					2017-05-18	274000	
ISCA-37425	5q35 recurrent (Sotos syndrome) region (includes NSD1)	5q35.2-q35.3	chr5:176301976-177620792	3	Sufficient evidence for dosage pathogenicity							3	Sufficient evidence for dosage pathogenicity	23599694	23913520	24819041				2014-04-10	117550	
ISCA-37424	10q22.3q23.2 recurrent region (LCR 3-LCR 4) (Includes BMPR1A)	10q22.3-q23.2	chr10:79923087-86979631	3	Sufficient evidence for dosage pathogenicity	20345475	21248748	24550761				1	Little evidence for dosage pathogenicity	21248748	26383923					2016-10-13	612242	
ISCA-37421	1q21.1 recurrent region (BP3-BP4, distal) (includes GJA5)	1q21.1-q21.2	chr1:147105904-147917509	3	Sufficient evidence for dosage pathogenicity							3	Sufficient evidence for dosage pathogenicity	22199024	23018752					2016-04-14	612474	612475
ISCA-37420	17q21.3 recurrent region (includes KANSL1)	17q21.3	chr17:45627800-46087514	3	Sufficient evidence for dosage pathogenicity	20301783	18628315					1	Little evidence for dosage pathogenicity	19502243	24649381	26565673				2020-08-10	610443	
ISCA-37418	17p11.2 recurrent (SMS/PLS) region (includes RAI1)	17p11.2	chr17:16906714-20309889	3	Sufficient evidence for dosage pathogenicity							3	Sufficient evidence for dosage pathogenicity	17357070	20188345					2013-11-21	182290	610883
ISCA-37417	Xp22.31 recurrent region (includes STS)	Xp22.31	chrX:6537771-8156913	3	Sufficient evidence for dosage pathogenicity							40	Dosage sensitivity unlikely							2021-07-01	308100	
ISCA-37415	16p13.11 recurrent region (BP2-BP3) (includes MYH11)	16p13.11	chr16:15417854-16198408	3	Sufficient evidence for dosage pathogenicity	18550696	19843651	24246141				2	Some evidence for dosage pathogenicity	30767844	24352232	30287593				2021-04-12		
ISCA-37411	15q13.3 recurrent region (BP4-BP5) (includes CHRNA7)	15q13	chr15:30900686-32153204	3	Sufficient evidence for dosage pathogenicity	18278044	19289393	19136953				1	Little evidence for dosage pathogenicity	19372089	18805830	26997942				2018-04-27	612001	
ISCA-37409	16p12.2 recurrent region (proximal) (includes EEF2K, CDR2)	16p12.2	chr16:21937124-22419483	2	Some evidence for dosage pathogenicity	20154674	24163246	23682798				0	No evidence available							2018-03-23		
ISCA-37408	2p15p16.1 region (includes BCL11A)	2p15-p16.1	chr2:58912065-62261736	3	Sufficient evidence for dosage pathogenicity	16963482	18245392	22579565				1	Little evidence for dosage pathogenicity	22726847	26278498					2016-06-08	612513	
ISCA-37406	16p13.3 region (includes CREBBP)	16p13.3	chr16:3725055-3880120	3	Sufficient evidence for dosage pathogenicity							1	Little evidence for dosage pathogenicity							2016-06-09	610543	
ISCA-37405	2q13 recurrent region (includes NPHP1)	2q13	chr2:110104531-110228181	30	Gene associated with autosomal recessive phenotype							40	Dosage sensitivity unlikely							2016-02-25		
ISCA-37404	15q11.2q13 recurrent (PWS/AS) region (Class 1, BP1-BP3)	15q11.2-q13.1	chr15:22782170-28134728	3	Sufficient evidence for dosage pathogenicity	7611294	22045295					3	Sufficient evidence for dosage pathogenicity	9106540	18374305	16840569				2013-11-26	176270	608636
ISCA-37401	11p13 (WAGR syndrome) region	11p13	chr11:31781961-32489442	3	Sufficient evidence for dosage pathogenicity							1	Little evidence for dosage pathogenicity	23701296						2016-05-24	194072	
ISCA-37400	16p11.2 recurrent region (proximal, BP4-BP5) (includes TBX6)	16p11.2	chr16:29638676-30188531	3	Sufficient evidence for dosage pathogenicity	20301775	18184952	21841781				3	Sufficient evidence for dosage pathogenicity	18184952	21731881	21841781				2017-02-09	611913	614671
ISCA-37397	22q11.2 recurrent region (distal type I, D-E/F)	22q11.21-q11.22	chr22:21562828-23306924	3	Sufficient evidence for dosage pathogenicity	23765049	21671380	18179902				3	Sufficient evidence for dosage pathogenicity	22140377	19193630	18414210				2015-03-12	611867	
ISCA-37396	15q24 recurrent region (LCR A-LCR D) (includes SIN3A)	15q24.1-q24.2	chr15:72671374-75680568	3	Sufficient evidence for dosage pathogenicity	22180641	19557438	19233321				1	Little evidence for dosage pathogenicity							2018-08-31	614294	
ISCA-37394	2q37.3 terminal region (includes HDAC4)	2q37.3	chr2:239032997-241988449	3	Sufficient evidence for dosage pathogenicity	19752160	23188045	25402011				0	No evidence available							2016-06-13	600430	
ISCA-37393	22q11.21 recurrent (Cat eye syndrome) region (includes CECR2)	22q11.1-q11.21	chr22:16912063-18109094	0	No evidence available	16708226						3	Sufficient evidence for dosage pathogenicity	22890013	22495764	11693792				2014-02-27		115470
ISCA-37392	7q11.23 recurrent (Williams-Beuren syndrome) region (includes ELN)	7q11.23	chr7:73330452-74728172	3	Sufficient evidence for dosage pathogenicity	20301427						3	Sufficient evidence for dosage pathogenicity	26610320						2015-08-06	194050	609757
ISCA-37390	5p15 terminal (Cri du chat syndrome) region	5p15.33-p15.2	chr5:37695-11347150	3	Sufficient evidence for dosage pathogenicity	15635506	11238681					2	Some evidence for dosage pathogenicity							2016-06-21	123450	
